These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Levamisol and cell-mediated immunity in sarcoidosis (author's transl)]. Votova V; Haskovcová H; Strejcek J Z Erkr Atmungsorgane; 1977 Aug; 149(2):207-11. PubMed ID: 610098 [TBL] [Abstract][Full Text] [Related]
25. Cutaneous sarcoidosis: an intriguing model of immune dysregulation. Ruocco E; Gambardella A; Langella GG; Lo Schiavo A; Ruocco V Int J Dermatol; 2015 Jan; 54(1):1-12. PubMed ID: 25312788 [TBL] [Abstract][Full Text] [Related]
26. [Serum angiotensin converting enzyme in sarcoidosis and other diseases. A review based on 2 1/2 years analysis of 1 601 patients]. Rømer FK Ugeskr Laeger; 1984 Jan; 146(5):335-40. PubMed ID: 6326363 [No Abstract] [Full Text] [Related]
28. [Sarcoidosis. Critical review on immunology in sarcoidosis and serum angiotensin converting enzyme in sarcoidosis (author's transl)]. Izumi T Kekkaku; 1978 Sep; 53(9):441-9. PubMed ID: 213635 [No Abstract] [Full Text] [Related]
29. Cutaneous sarcoidosis: clinical features and management. Sharma OP Chest; 1972 Apr; 61(4):320-5. PubMed ID: 5020251 [No Abstract] [Full Text] [Related]
30. [Immunologic and biochemical aspects of sarcoidosis]. Bartmann K Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():506-16. PubMed ID: 6316310 [No Abstract] [Full Text] [Related]
31. Clinical and biochemical aspects of sarcoidosis. With special reference to angiotensin-converting enzyme (ACE). Rømer FK Acta Med Scand Suppl; 1984; 690():3-96. PubMed ID: 6097101 [TBL] [Abstract][Full Text] [Related]
32. [Cutaneous manifestations of sarcoidosis]. Descamps V; Bouscarat F Ann Dermatol Venereol; 2016 Jan; 143(1):39-50. PubMed ID: 26804434 [TBL] [Abstract][Full Text] [Related]
33. Methotrexate therapy in cutaneous sarcoidosis. Webster GF; Razsi LK; Sanchez M; Shupack JR Ann Intern Med; 1989 Sep; 111(6):538-9. PubMed ID: 2774378 [No Abstract] [Full Text] [Related]
34. [Evaluation of cutaneous sarcoidosis]. Crickx B Ann Dermatol Venereol; 1992; 119(8):581-2. PubMed ID: 1485766 [No Abstract] [Full Text] [Related]
35. Serial observations of angiotensin-converting enzyme and pulmonary function in sarcoidosis. Weaver LJ; Solliday NH; Celic L; Cugell D Arch Intern Med; 1981 Jun; 141(7):931-4. PubMed ID: 6263205 [TBL] [Abstract][Full Text] [Related]
36. [Serum angiotensin convertase activity and clinical course of sarcoidosis. Course studies in Löfgren syndrome]. Sehrt I; Christ R Z Erkr Atmungsorgane; 1985; 164(1):39-42. PubMed ID: 2984849 [TBL] [Abstract][Full Text] [Related]
37. Immunology of sarcoidosis. James DG; Williams WJ Am J Med; 1982 Jan; 72(1):5-8. PubMed ID: 6277191 [No Abstract] [Full Text] [Related]
38. Follow-up on angiotensin-converting enzyme in serum of patients with sarcoidosis. Baur X; Fruhmann G; Dahlheim H Respiration; 1981; 41(2):133-8. PubMed ID: 6266000 [TBL] [Abstract][Full Text] [Related]
39. Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis. Pignone AM; Rosso AD; Fiori G; Matucci-Cerinic M; Becucci A; Tempestini A; Livi R; Generini S; Gramigna L; Benvenuti C; Carossino AM; Conforti ML; Perfetto F J Pineal Res; 2006 Sep; 41(2):95-100. PubMed ID: 16879313 [TBL] [Abstract][Full Text] [Related]
40. Laryngeal and cutaneous sarcoidosis treated with methotrexate. Henderson CA; Ilchyshyn A; Curry AR J R Soc Med; 1994 Oct; 87(10):632-3. PubMed ID: 7966120 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]